Dutch Arthritis Association   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Amsterdam Netherlands

Organization Overview

First Clinical Trial
2000
NCT00391924
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Dutch Arthritis Association

Active Ingredients

Drugs in Phase 4 Trials (3)

azathioprine (imuran) (1 trial)

etanercept (enbrel) (1 trial)

lidocaine (xylocaine) (1 trial)

Drugs in Phase 3 Trials (1)

rituximab (rituxan) (2 trials)

Drugs in Phase 2 Trials (1)

dehydroepiandrosterone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 4)

Arthritis, Juvenile (Phase 4)

Lupus Erythematosus, Systemic (Phase 2)

Sjogren's Syndrome (Phase 2)

Syndrome (Phase 2)

Tendinopathy (Phase 4)

Vasculitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 5